Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), today released the following note authored by its Chairman and CEO, Jim Joyce. Dear Readers, Aside from ongoing COVID infections and